神经修復市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按类型、技术、按应用、地区和竞争细分

神经修復市场在2022 年实现估值102.4 亿美元，并预计在预测期内大幅成长，预计到2028 年复合年增长率为10.38%。神经修復市场目前正在经历强劲扩张，受到以下多种因素的推动：从根本上重塑医疗保健和科技的交叉点。全球人口老化趋势导致帕金森氏症、癫痫和脊髓损伤等神经系统疾病的盛行率增加，从而产生了对创新解决方案的巨大需求。尖端技术的进步，特别是在脑机介面（BCI）和神经植入领域，正在为神经假体的发展带来前所未有的可能性。此外，政府和私人投资者的资金增加，加上支持性的监管框架，创造了有利于该领域研究和创新的环境。

患者对提高生活品质的期望提高、对定制神经修復设备的渴望以及对可用选择的认识增强，进一步推动了该市场的扩张。学术界、产业参与者和医疗机构的合作正在加速进展，而製造商之间的竞争则激励着产品的不断改进和成本的降低。除了医疗保健领域之外，神经修復市场在非医疗应用领域也展现了前景，涵盖游戏和辅助技术等领域，从而扩大了其范围和影响力。

在这个充满活力的商业环境中，处于神经假体研究和发展前沿的公司处于战略地位，可以利用这些新兴的机会。随着市场的成熟和全球社会对神经假体解决方案的接受程度越来越高，能够提供创新、有效且具有成本效益的设备的企业将在塑造医疗保健的未来以及人与机器之间的互动方面发挥关键作用。

市场概况
预测期	2024-2028
2022 年市场规模	102.4亿美元
2028 年市场规模	185亿美元
2023-2028 年复合年增长率	10.38%
成长最快的细分市场	脊髓刺激
最大的市场	北美洲

主要市场驱动因素

神经系统疾病的发生率上升

神经系统疾病发生率的上升是神经修復市场蓬勃发展的关键驱动力。神经系统疾病涵盖多种疾病，包括帕金森氏症、癫痫、脊髓损伤、阿兹海默症和中风等。几个关键因素导致这些疾病的盛行率不断增加，加剧了对神经假体解决方案的需求。

技术进步

技术进步处于推动神经修復市场快速成长的最前线。这些技术创新透过扩展神经义肢设备的可能性和功能，提高其有效性、安全性和可及性，正在彻底改变该领域。

最重要的技术突破之一是脑机介面（BCIs）的开发。脑机介面可以实现大脑和外部设备之间的直接通信，使神经系统受损的人能够控制义肢、计算机，甚至仅透过思想进行交流。微型化和改进的电极技术使脑机介面更加实用和用户友好，为神经假体应用开闢了新的途径。

神经植入物也受益于技术进步。这些植入神经系统的微型设备可以以更高的精确度和效率刺激或记录神经活动。改良的材料、无线通讯和生物相容性涂层提高了神经植入物的寿命和功能，使其长期使用更加可靠。

此外，机器人技术和人工智慧（AI）的进步与神经修復学产生了协同作用。义肢现在配备了人工智慧驱动的演算法，可以实现自然和自适应的运动，从而提高截肢者的生活品质。人工智慧还可以帮助更准确地解码神经讯号，增强对神经义肢设备的控制。

材料科学的创新促进了用于神经介面的柔性和生物相容性材料的开发，降低了组织损伤和排斥的风险。此外，3D 列印和奈米技术使得能够根据个别患者的需求创建客製化的神经假体设备。

主要市场挑战

生物相容性和安全性

生物相容性和安全性挑战是神经假体市场最关心的问题之一。神经修復装置通常直接与神经系统连接，必须与身体无缝集成，以避免不良反应并确保长期有效性。

一项主要挑战是潜在的免疫反应和组织排斥。当异物或装置被植入时，人体的免疫系统会将它们视为威胁并引发免疫反应。这可能会导致发炎、不适，严重时还会导致设备排斥。确保神经修復材料具有生物相容性并且不会引发免疫反应是一个关键障碍。

另一个安全问题涉及感染风险，特别是对于具有突破人体保护屏障的外部组件的设备。感染可能会损害设备的功能和患者的健康，因此需要仔细注意设备构造中使用的卫生和材料。

长期安全性和可靠性是重要的考虑因素。随着时间的推移，材料的磨损、潜在的腐蚀或植入组件的降解可能会引起人们对设备功能和患者健康的担忧。这需要持续监控、维护，在某些情况下还需要更换设备。

成本和可近性

成本和可近性挑战是神经修復市场的重大障碍，限制了这些改变生活的技术向更广泛的人群的普及。

首先，神经假体设备可能非常昂贵，包括研发、製造、外科手术和持续维护的成本。这种高昂的成本给医疗保健系统和个人带来了沉重的负担，通常使财力有限的人无法获得这些先进的治疗方法。

可访问性是另一个关键问题。在许多地区，特别是在低收入国家或服务不足的社区，获得医疗保健服务和专门的神经修復专业知识的机会有限。这种可近性的缺乏进一步加剧了医疗保健结果的差异，因为本来可以从神经修復干预措施中受益的个人却别无选择。

主要市场趋势

脑机介面 (BCI) 的进步

脑机介面 (BCI) 的进步代表了神经修復市场的变革趋势。脑机介面是一种复杂的技术，可以实现人脑与外部设备之间的直接通信，为患有神经系统疾病和残疾的个人提供了重要的机会。

一项显着的进步是非侵入性脑机介面的发展。这些系统通常依赖脑电图（EEG），让使用者只需透过思考即可控制设备或应用程序，而无需进行侵入性外科手术。非侵入式脑机介面正变得更加用户友好、便携和易于使用，为辅助技术、游戏和通讯等领域更广泛的应用打开了大门。

侵入式脑机介面也取得了重大进展。这些设备涉及将电极直接植入大脑，以更高的精确度和分辨率记录或刺激神经活动。电极材料、植入技术和讯号处理的进步提高了侵入式脑机介面的寿命、可靠性和安全性。因此，人们正在探索它们的应用，例如恢復肢体功能、治疗神经系统疾病，甚至增强认知能力。

此外，结合侵入性和非侵入性方法的混合脑机介面正在出现，在精确度和可访问性之间提供平衡。这些混合系统旨在为使用者提供两全其美的功能，以实现稳健的控制，同时最大限度地降低手术风险。

神经植入与神经调节

神经植入物和神经调节是神经修復市场不可或缺的组成部分，代表着旨在恢復或增强神经功能的强大技术。神经植入物通常采用小型装置或电极的形式，旨在透过手术植入神经系统，从而与神经活动直接相互作用。这些植入物取得了重大进步，包括使用生物相容性材料、小型化和改进的电极设计，使它们更安全、更有效。

另一方面，神经调节涉及使用电或化学刺激来调节神经活动。深部脑部刺激 (DBS)、脊髓刺激 (SCS) 和迷走神经刺激 (VNS) 等技术用于治疗各种神经系统疾病，例如巴金森氏症、慢性疼痛和癫痫。神经调节的进步包括开发更精确和适应性的刺激模式、可自订的疗法以及整合回馈机制以优化治疗结果。

这些神经植入和神经调节的创新正在扩大神经系统疾病患者的治疗选择，为改善症状管理、提高生活品质和减少对药物的依赖提供了潜力。随着研究和开发的继续，神经修復市场预计这些技术的复杂性和适用性将进一步增长，以解决越来越多的神经系统疾病和病症。

细分市场洞察

类型洞察

输入神经修復细分市场在神经修復市场中占据主导地位，预计未来几年将继续扩大。首先，输入神经修復部分主要包括脑机介面（BCI）和神经植入等技术，有助于将资讯或指令直接输入神经系统。这些技术在恢復失去的感觉和运动功能方面具有巨大的前景，使其成为神经系统疾病或残疾患者备受追捧的解决方案。

其次，输入神经修復学的进步非常显着。尤其是脑机接口，已经取得了重大突破，使得人脑和外部设备之间的通讯更加准确和高效。这开启了多种应用，从针对行动障碍人士的辅助技术，到针对听力或视力缺陷人士的感觉恢復。此外，神经系统疾病的日益流行，加上人口老化的不断增长，对输入神经修復术可以提供的解决方案产生了强劲的需求。随着神经系统疾病持续影响全球数百万人，对创新技术来提高生活品质的需求变得越来越明显。此外，研究和开发投资以及学术机构和私营部门之间的合作加速了输入神经修復术的开发和商业化。这推动了竞争，刺激了创新，并促进了市场成长。

区域洞察

由于多种因素的综合作用，北美地区已成为 2022 年神经修復市场的领导者，使其成为神经修復创新和采用的蓬勃发展中心。首先，北美受益于由尖端研究机构、领先的医疗设施和创新技术公司组成的强大生态系统。这种协同作用培育了创新和协作的文化，促进了神经假体技术的快速进步。着名学术机构和研究中心的存在确保了突破性发现的源源不绝和训练有素的人才库。此外，北美强大的医疗基础设施和高医疗支出水准为神经修復解决方案的开发和采用提供了有利的环境。完善的监管框架（例如美国 FDA 提供的监管框架）可确保神经义肢设备符合严格的安全性和有效性标准，从而增强患者和投资者的信心。该地区还拥有大量患有神经系统疾病和残疾的患者，包括帕金森氏症、脊髓损伤和截肢等疾病。这群庞大的患者群推动了神经修復设备的市场需求。此外，北美神经修復治疗的优惠报销政策和保险范围提高了可及性，使患者更容易获得这些技术。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球神经假体市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（输出神经修復和输入神经修復）
  • 按技术（脊髓刺激、深部脑部刺激、迷走神经刺激和其他技术）
  • 按应用（帕金森氏症、阿兹海默症、癫痫、听觉处理障碍、眼科疾病和其他应用）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美神经假体市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按应用
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲神经修復术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按应用
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区神经修復市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按应用
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲神经假体市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按应用
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲神经修復市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按应用
  • 按国家/地区
• MEA：国家分析
  • 南非神经修復术
  • 沙乌地阿拉伯神经修復术
  • 阿联酋神经修復术

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购

第 13 章：全球神经修復市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代治疗类型的威胁

第15章：竞争格局

• 商业概览
• 服务内容
• 最近的发展
• 主要人员
• SWOT分析
  • Medtronic PLC
  • LivaNova PLC
  • Demant A/S
  • MED-EL Corporation
  • Cochlear Limited
  • Abbott Laboratories
  • Boston Scientific Corp
  • Second Sight Medical Products, Inc.
  • Retina Implant AG
  • NeuroPace Inc

第 16 章：策略建议

第 17 章：关于我们与免责声明

The Neuroprosthetics Market achieved a valuation of USD 10.24 Billion in 2022 and is poised for substantial growth in the forecast period, with an anticipated CAGR of 10.38% through 2028. The Neuroprosthetics market is currently experiencing robust expansion, driven by a convergence of factors that are fundamentally reshaping the intersection of healthcare and technology. The global demographic trend toward an aging population has led to an increased prevalence of neurological disorders such as Parkinson's disease, epilepsy, and spinal cord injuries, thereby generating significant demand for innovative solutions. Cutting-edge technological advancements, particularly in the realm of brain-computer interfaces (BCIs) and neural implants, are unlocking unprecedented possibilities for the development of Neuroprosthetics. Furthermore, augmented funding from both governments and private investors, coupled with supportive regulatory frameworks, has fostered an environment conducive to research and innovation within this field.

Elevated patient expectations for an improved quality of life, the desire for customized Neuroprosthetics devices, and an enhanced awareness of available options are further fueling the expansion of this market. Collaborative efforts involving academia, industry players, and healthcare institutions are expediting progress, while competition among manufacturers is incentivizing continuous product enhancements and cost reductions. Beyond the realm of healthcare, the Neuroprosthetics market is demonstrating promise in non-medical applications, spanning areas such as gaming and assistive technology, thus broadening its scope and impact.

Within this dynamic business landscape, companies at the forefront of Neuroprosthetics research and development are strategically positioned to capitalize on these burgeoning opportunities. As the market matures and the global community becomes increasingly receptive to Neuroprosthetics solutions, businesses that can offer innovative, efficacious, and cost-effective devices are poised to play a pivotal role in shaping the future of healthcare and the interactions between humans and machines.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 10.24 Billion
Market Size 2028	USD 18.50 Billion
CAGR 2023-2028	10.38%
Fastest Growing Segment	Spinal Cord Stimulation
Largest Market	North America

Key Market Drivers

Rising Incidence of Neurological Disorders

The rising incidence of neurological disorders is a pivotal driver behind the burgeoning Neuroprosthetics market. Neurological disorders encompass a wide spectrum of conditions, including Parkinson's disease, epilepsy, spinal cord injuries, Alzheimer's disease, and stroke, among others. Several key factors contribute to the increasing prevalence of these disorders, thereby intensifying the demand for Neuroprosthetics solutions.

First and foremost, the global aging population plays a significant role in the escalating incidence of neurological disorders. As individuals age, their risk of developing conditions like Alzheimer's and Parkinson's disease increases, making these disorders more prevalent in older demographics. With an aging population in many parts of the world, the pool of potential Neuroprosthetics recipients expands.

Furthermore, lifestyle changes, environmental factors, and genetics also contribute to the rising incidence of neurological disorders. Sedentary lifestyles, unhealthy diets, and increased stress levels can contribute to conditions such as stroke and depression. Environmental factors like pollution and exposure to toxins can increase the risk of neurological diseases. Genetic predisposition can also be a significant factor in various neurological disorders.

The growing awareness and diagnosis of these conditions also contribute to the apparent increase in incidence. As medical knowledge and diagnostic tools advance, more individuals are being identified and treated for neurological disorders, further underscoring the need for Neuroprosthetics interventions.

Advancements in Technology

Advancements in technology are at the forefront of driving the rapid growth of the Neuroprosthetics market. These technological innovations are revolutionizing the field by expanding the possibilities and capabilities of Neuroprosthetics devices, enhancing their effectiveness, safety, and accessibility.

One of the most significant technological breakthroughs is in the development of brain-computer interfaces (BCIs). BCIs enable direct communication between the brain and external devices, allowing individuals with neurological impairments to control prosthetic limbs, computers, or even communicate through thought alone. Miniaturization and improved electrode technology have made BCIs more practical and user-friendly, opening new avenues for Neuroprosthetics applications.

Neural implants have also benefited from technological advancements. These tiny devices, implanted into the nervous system, can stimulate or record neural activity with increasing precision and efficiency. Improved materials, wireless communication, and biocompatible coatings have enhanced the longevity and functionality of neural implants, making them more reliable for long-term use.

Furthermore, advancements in robotics and artificial intelligence (AI) have synergized with Neuroprosthetics. Prosthetic limbs are now equipped with AI-driven algorithms that enable natural and adaptive movements, improving the quality of life for amputees. AI can also assist in decoding neural signals more accurately, enhancing the control of Neuroprosthetics devices.

Innovations in materials science have led to the development of flexible and biocompatible materials for neural interfaces, reducing the risk of tissue damage and rejection. Additionally, 3D printing, and nanotechnology have enabled the creation of customized Neuroprosthetics devices tailored to individual patient needs.

Key Market Challenges

Biocompatibility and Safety

Biocompatibility and safety challenges are among the foremost concerns in the Neuroprosthetics market. Neuroprosthetics devices, which often interface directly with the nervous system, must seamlessly integrate with the body to avoid adverse reactions and ensure long-term effectiveness.

One primary challenge is the potential for immune responses and tissue rejection. When foreign materials or devices are implanted, the body's immune system can perceive them as threats and mount immune responses. This can lead to inflammation, discomfort, and, in severe cases, the rejection of the device. Ensuring that Neuroprosthetics materials are biocompatible and do not trigger immune reactions is a critical hurdle.

Another safety concern relates to the risk of infection, especially for devices with external components that breach the body's protective barriers. Infections can compromise both the device's functionality and the patient's health, necessitating careful attention to hygiene and materials used in device construction.

Long-term safety and reliability are essential considerations. Over time, wear and tear on materials, potential corrosion, or the degradation of implanted components can raise concerns about device function and patient well-being. This requires continuous monitoring, maintenance, and, in some cases, device replacement.

Costs and Accessibility

Costs and accessibility challenges are significant barriers within the Neuroprosthetics market, limiting the reach of these life-changing technologies to a broader population.

Firstly, Neuroprosthetics devices can be prohibitively expensive, encompassing costs for research and development, manufacturing, surgical procedures, and ongoing maintenance. This high-cost places a substantial burden on healthcare systems and individuals, often making these advanced treatments inaccessible to those with limited financial resources.

Accessibility is another crucial issue. In many regions, especially in lower-income countries or underserved communities, access to healthcare services and specialized Neuroprosthetics expertise is limited. This lack of accessibility further exacerbates the disparities in healthcare outcomes, as individuals who could benefit from Neuroprosthetics interventions are left without options.

Key Market Trends

Advancements in Brain-Computer Interfaces (BCIs)

Advancements in Brain-Computer Interfaces (BCIs) represent a transformative trend within the Neuroprosthetics market. BCIs are sophisticated technologies that enable direct communication between the human brain and external devices, offering profound opportunities for individuals with neurological disorders and disabilities.

One notable advancement is the development of non-invasive BCIs. These systems, often relying on electroencephalography (EEG), allow users to control devices or applications simply by thinking, without the need for invasive surgical procedures. Non-invasive BCIs are becoming more user-friendly, portable, and accessible, opening the door to broader applications in fields like assistive technology, gaming, and communication.

Invasive BCIs have also seen significant progress. These devices involve implanting electrodes directly into the brain to record or stimulate neural activity with higher precision and resolution. Advancements in electrode materials, implantation techniques, and signal processing have improved the longevity, reliability, and safety of invasive BCIs. As a result, they are being explored for applications such as restoring limb function, treating neurological disorders, and even enhancing cognitive capabilities.

Furthermore, hybrid BCIs that combine both invasive and non-invasive approaches are emerging, offering a balance between precision and accessibility. These hybrid systems aim to provide users with the best of both worlds, allowing for robust control while minimizing surgical risks.

Neural Implants and Neuromodulation

Neural implants and neuromodulation are integral components of the Neuroprosthetics market, representing powerful technologies that aim to restore or enhance neurological function. Neural implants, often in the form of small devices or electrodes, are designed to be surgically implanted into the nervous system, allowing for direct interaction with neural activity. These implants have seen significant advancements, including the use of biocompatible materials, miniaturization, and improved electrode design, making them safer and more effective.

Neuromodulation, on the other hand, involves the use of electrical or chemical stimulation to modulate neural activity. Techniques like deep brain stimulation (DBS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS) are used to treat various neurological disorders such as Parkinson's disease, chronic pain, and epilepsy. Advancements in neuromodulation include the development of more precise and adaptive stimulation patterns, customizable therapies, and the integration of feedback mechanisms to optimize treatment outcomes.

These innovations in neural implants and neuromodulation are expanding treatment options for individuals with neurological conditions, offering the potential for improved symptom management, enhanced quality of life, and reduced reliance on medication. As research and development continue, the Neuroprosthetics market is expected to see further growth in the sophistication and applicability of these technologies, addressing an increasing range of neurological disorders and conditions.

Segmental Insights

Type Insights

The Input Neural Prosthetics Segment dominates the Neuroprosthetics market and is predicted to continue expanding over the coming years. Firstly, the Input Neural Prosthetics segment primarily encompasses technologies like Brain-Computer Interfaces (BCIs) and neural implants that facilitate the direct input of information or commands into the nervous system. These technologies hold immense promise in restoring lost sensory and motor functions, making them highly sought-after solutions for patients suffering from neurological disorders or disabilities.

Secondly, advancements in Input Neural Prosthetics have been remarkable. BCIs, in particular, have witnessed significant breakthroughs, enabling more accurate and efficient communication between the human brain and external devices. This has opened up diverse applications, from assistive technologies for individuals with mobility impairments to sensory restoration for those with hearing or vision deficits. Additionally, the increasing prevalence of neurological disorders, coupled with a growing aging population, has created a robust demand for solutions that Input Neural Prosthetics can provide. As neurological conditions continue to affect millions worldwide, the need for innovative technologies to enhance the quality of life becomes increasingly evident. Furthermore, research and development investments, as well as collaborations between academic institutions and the private sector, have accelerated the development and commercialization of Input Neural Prosthetics. This has driven competition, spurred innovation, and contributed to market growth.

Regional Insights

The North America region has established itself as the leader in the Neuroprosthetics Market in 2022 due to a combination of factors that make it a thriving hub for Neuroprosthetics innovation and adoption. First and foremost, North America benefits from a robust ecosystem of cutting-edge research institutions, leading medical facilities, and innovative technology companies. This synergy fosters a culture of innovation and collaboration, enabling rapid advancements in Neuroprosthetics technologies. The presence of renowned academic institutions and research centres ensures a steady flow of breakthrough discoveries and a well-trained talent pool. Moreover, North America's strong healthcare infrastructure and high healthcare expenditure levels provide a conducive environment for the development and adoption of Neuroprosthetics solutions. Well-established regulatory frameworks, such as those provided by the FDA in the United States, ensure that Neuroprosthetics devices meet rigorous safety and efficacy standards, instilling confidence in both patients and investors. The region also boasts a large patient population with neurological disorders and disabilities, including conditions like Parkinson's disease, spinal cord injuries, and limb amputations. This substantial patient base drives market demand for Neuroprosthetics devices. Furthermore, favourable reimbursement policies and insurance coverage for Neuroprosthetics treatments in North America enhance accessibility, making these technologies more attainable for patients.

Key Market Players

• Medtronic PLC

• LivaNova PLC

• Demant A/S

• MED-EL Corporation

• Cochlear Limited

• Abbott Laboratories

• Boston Scientific Corp

• Second Sight Medical Products, Inc.

• Retina Implant AG

• NeuroPace Inc

Report Scope:

In this report, the Neuroprosthetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neuroprosthetics Market, Type:

• Output Neural Prosthetics
• Input Neural Prosthetics

Neuroprosthetics Market, Technique:

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Vagus Nerve Stimulation
• Other Techniques

Neuroprosthetics Market, Application:

• Parkinson's Disease
• Alzheimer's Disease
• Epilepsy
• Auditory Processing Disorders
• Ophthalmic Disorders
• Other Applications

Neuroprosthetics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• Italy
• France
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Neuroprosthetics Market.

Available Customizations:

• Neuroprosthetics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Neuroprosthetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Output Neural Prosthetics and Input Neural Prosthetics)
  • 5.2.2. By Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, and Other Techniques)
  • 5.2.3. By Application (Parkinson's Disease, Alzheimer's Disease, Epilepsy, Auditory Processing Disorders, Ophthalmic Disorders, and Other Applications)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map

6. North America Neuroprosthetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neuroprosthetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Neuroprosthetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Neuroprosthetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application

7. Europe Neuroprosthetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Neuroprosthetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
  • 7.3.2. United Kingdom Neuroprosthetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
  • 7.3.3. Italy Neuroprosthetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
  • 7.3.4. France Neuroprosthetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Neuroprosthetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application

8. Asia-Pacific Neuroprosthetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Neuroprosthetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
  • 8.3.2. India Neuroprosthetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Neuroprosthetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Neuroprosthetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Neuroprosthetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Application

9. South America Neuroprosthetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Neuroprosthetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Neuroprosthetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Neuroprosthetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application

10. Middle East and Africa Neuroprosthetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Neuroprosthetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Neuroprosthetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Neuroprosthetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions

13. Global Neuroprosthetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Medtronic PLC
  • 15.5.2. LivaNova PLC
  • 15.5.3. Demant A/S
  • 15.5.4. MED-EL Corporation
  • 15.5.5. Cochlear Limited
  • 15.5.6. Abbott Laboratories
  • 15.5.7. Boston Scientific Corp
  • 15.5.8. Second Sight Medical Products, Inc.
  • 15.5.9. Retina Implant AG
  • 15.5.10. NeuroPace Inc

16. Strategic Recommendations

17. About Us & Disclaimer